Archives

by in
Entry Author Date Location
Dicerna Shares Triple on First Trading Day, Close at $46 01/30/14 Boston
Dicerna Prices Upsized IPO at $15 Per Share, Starts Trading Thursday 01/29/14 Boston
Dicerna Joins Biotech IPO Queue, Plans $69M Raise 01/02/14 Boston
Personalis Lands $22,000,000 Series B Funding Round 10/07/13 San Francisco
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
Dicerna Snags $60M as RNAi Heats Up Again 08/01/13 Boston
Dicerna Pharmaceuticals Obtains $60,000,000 Series C Funding 08/01/13 Boston
eFFECTOR Therapeutics Lands $45,000,000 Series A Funding 05/21/13 San Diego
Avedro Secures $43,000,000 Series D Funding 03/06/13 Boston
Gynesonics Lands $21,000,000 Series D Financing Round 02/20/13 San Francisco
Sonitus Medical Obtains $25,000,000 Series D Financing 05/15/12 San Francisco
Sientra Secures $65,000,000 Series C Round 03/29/12 San Diego
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers 01/27/12 Boston
Portola Grabs $45M Upfront From Biogen Idec to Develop Autoimmune Drugs 10/27/11 San Francisco
Q2 Funding in NYC: “Shopping Facilitators” and Foursquare Rule 07/22/11 New York
BayBio’s Annual Conference, Tweet by Tweet 04/22/11 San Francisco
Dicerna Gets Glaxo’s SR One to Join Investor Syndicate 10/21/10 Boston
San Diego’s Zogenix Moving Fast to Commercialize Drug-and-Device Combo 08/17/10 San Diego
Cypress Bio Gets Buyout Offer, Trius Prepares for IPO, Arena Gains Following Vivus Setback, & More San Diego Life Sciences News 07/22/10 San Diego
Biogen Names CEO, Glaser Leaves Partners, SV Closes $523M Fund, & More Boston-Area Life Sciences News 07/02/10 Boston
$5M Debt Deal for Dicerna Pharma 06/30/10 Boston
Avila Therapeutics Strikes $209M Lung Cancer Deal with Clovis Oncology 05/25/10 Boston
Clovis Oncology Secures $65,635,000 New Financing 12/31/09 Boulder/Denver
Novexel Offers Exit to Atlas and Abingworth 12/24/09 Boston
With Extra Dose of Cash, Zogenix Raises VC Round to $71M for Launch of Migraine Treatment 12/08/09 San Diego
Investors Inject $51M B Round into Zogenix to Combat Migraines 09/24/09 San Diego
Intellikine, Stocked With Cash, Pushes Portfolio of Drugs Against Biology’s Hot Targets 08/18/09 San Diego
San Diego’s Slight Rebound in Venture Investing Reflects Broader Trends—Region’s Top Deals List 07/21/09 San Diego
Intellikine Raises $28.5M, Cadence Awaits FDA Action, Somaxon Seeks FDA Approval Again for Insomnia Drug, & More San Diego Life Sciences News 07/09/09 San Diego
Intellikine Attracts Novartis, Biogen, and Others for $51M Second Round 07/09/09 San Diego
Page 1 of 2 next page »